Table 3.
Novel formulations of naringin
| Purpose of study | Formulation approach | Objective | Method of preparation | Result | Reference |
|---|---|---|---|---|---|
| To prepare deformable liposomes of Naringin for improved anti-inflammatory activity | Deformable liposomes | For anti-inflammatory skin activity deformable liposomes of Naringin was made | Thin- film hydration technique | When compared to marketed preparation, the liposomes showed increased anti-inflammatory activity in an in-vitro assay | (Pleguezuelos-Villa et al. 2018 ▶) |
| To prevent development of resistance toward chemotherapeutic agents by combining Naringin and paclitaxel | Mixed micelles | To develop anticancer medicine with combining paclitaxel and Naringin | Solvent diffusion method | Naringin synergistically increased its intracellular intake and 65 % in-vitro cytotoxicity | (Jabri et al. 2019 ▶) |
| To develop formulation which may prevent Naringin release bursting and osteogenesis | Microspheres | To prepare Naringin-loaded microsphere/sucrose acetate isobutyrate hybrid depots and improve osteogenesis | Single-nozzle-electro-spraying setup | Microspheres showed effective biocompatibility and osteogenic potential in-vitro. Ng-m-SAIB may demonstrate promising for bone repair to be a sustained release carrier |
(Yang et al. 2019 ▶) |
| To incorporate into sunscreen creams which may increase protection against U.V. radiation | Ethosomes of Naringin | To improve the penetrating capacity and retention capacity of Naringin into sunscreen creams | Hot method and mechanical dispersion method | Ethosomes showed a pronounced skin penetration for Naringin across the skin and had a good skin retention and U.V. protection ability | (Gollavilli et al. 2020 ▶) |
| To prepare a dosage form in form of nano-capsule which have good bioavailability, bioavailability, biotransformation and distribution | Naringin-loaded Nano-capsules | To formulate nano-capsules of Naringin and to evaluate the toxicity | Interfacial- deformation technique | The ethosomes showed desired pharmacokinetic effect and there was no indication of toxicity by nano-capsules | (Budel et al. 2020 ▶) |
| To prepare a gum tragacanth stabilized green nanoparticles for increasing bactericidal activity | Naringin nanoparticles | To formulate green gold gum tragacanth loaded Naringin nanoparticles | Through magnetic stirring the color change was observed | Naringin's bactericidal potential was increased when it was loaded into AuNPs against different bacterial strains | (Rao et al. 2017 ▶) |
| To prepare a dosage form with increased drug release | Ternary nanoparticles containing amylose, alpha-linoleic acid, and beta-lactoglobulin complexed with Naringin | To formulate Naringin-nanoparticle inclusion complex for increased bio accessibility and thereby bioavailability | Through magnetic stirring the preparation of ternary nanoparticles and inclusion complex with Naringin was prepared | Naringin gradually released from the complex mixture and nanoparticles are promising carrier for increased bioavailability of Naringin | (Feng et al. 2017 ▶) |
| To prepare high catalytic properties of alpha-amalyse | Enzyme immobilized in magnetic nanoparticles of Naringin. | To formulate alpha-amalyse immobilized functionalized Magnetic NPs | Magnetite nanoparticles followed by immobilization of alpha-amalyse onto magnetic nanoparticle containing Naringin | Improvement in enzyme catalytic properties made nano-biocatalyst a good candidate in bio industrial applications | (Defaei et al. 2018 ▶) |
| To prepare a formulation having better anti-tumor activity of Naringin against hepatocellular carcinoma | Nanostructured lipid carrier with Naringin & coix seed oil. | To develop a Nanostructured lipid carrier containing Naringin and coix seed oil for the treatment of hepatocellular carcinoma | Ultrasonic- melt emulsification method. | The drug release and synergistic antitumor effect provides new insight against cancer | (Zhu et al. 2020 ▶) |
| To develop sustainable agriculture by using Naringin novel formulation | Naringin & citric acid in polycaprolactone microcapsules | Plant development and sustainable agriculture with polycaprolactone microcapsules containing Naringin & citric acid | Combination of a double emulsion method of water-in-oil-in-water and a solvent evaporation technique | The use of PCL 45000 Mw for the synthesis of MCs containing citric acid or Naringin may be a viable alternative to the current need for environmentally friendly agricultural practices. MCs containing Naringin have a 30-day slow release that is unaffected by pH, indicating that it should be used in soils with a variety of characteristics and promote the continuous supply (slow release) of nutrients to plants | (Cesari et al. 2020 ▶) |
| To prepare a dosage form in order to increase solubility of Naringin | Naringin loaded polycaprolactone microspheres. | Naringin loaded polycaprolactone microspheres for increased solubility of Naringin . |
Solvent evaporation method | Three-level Box-Behnken configuration can be used to configure a Naringin-loaded polycaprolactone microspheres based oral suspension, demonstrating that Naringin solubility is greatly improved as evidenced by the optimized suspension's particle size | (Ghosal et al. 2018 ▶) |
| To increase water solubility, permeability and Bioavailability of Naringin |
Naringin polymeric micelles | To make polymeric Naringin micelles based from pluronic F68 and test their antitumor activity in mice with Ehrlich ascites carcinoma | Thin film hydration technique | 1:50 polymeric micelles containing PF68 may be a promising nanocarrier for the phytopharmaceutical Naringin, with increased water solubility, permeability, and bioavailability, and also increased antitumor and antiulcer activities | (Mohamed et al. 2018 ▶) |
Ng-m-SAIB: Naringin-loaded microsphere/sucrose acetate isobutyrate; AuNPs: Gold nanoparticles; PCL: Polycaprolactone; Mw: Molecular weight; MCs: Microcapsules; PF68: Pluronic-F68